Facing sluggish conditions in its largest businesses, Boston Scientific Corp. plans to grow faster than the overall market, take share from competitors, and expand into faster growing niches, its top executive told investors Tuesday morning.

Michael Mahoney, who joined the Natick-based medical device maker in 2011 and was elevated to chief executive last November, outlined his strategy at a New York meeting with stock analysts that was webcast to the company’s investors.